Thermo Fisher Scientific Inc. is proposing to build a new “corporate hangar and office facility” at the Portsmouth ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story ... This ...

The collaboration agreement will enable Mainz Biomed and Thermo Fisher to jointly develop and potentially commercialize Mainz Biomed’s Next Generation colorectal cancer screening product. The ...

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Seer (SEER) announced a co-marketing and sales agreement with Thermo Fisher (TMO) to jointly promote Seer’s Proteograph Product Suite ...

The global antioxidants reagents market is poised for significant growth, with projected sales reaching USD 5,543.5 million by 2034, up from an estimated USD 2,615.8 million in 2024. According to the ...

The global electrophoresis market is poised for significant expansion, with market value anticipated to grow from USD 2,268.8 million in 2023 to a projected USD 3,523.5 million by 2033. This robust ...

Thermo Fisher Scientific Inc. (NYSE:TMO) offers life sciences solutions, analytical instruments, specialty diagnostics, and ...